BPC-157 / TB-500

This lyophilized vial contains a synergistic blend of two highly researched peptides: Body Protection Compound-157 (BPC-157) and Thymosin Beta-4 Fragment (TB-500). Each vial provides 5mg of BPC-157 and 5mg of TB-500, designed to investigate the combined effects of these compounds on tissue repair and recovery pathways. BPC-157 is a synthetic pentadecapeptide known in preclinical models…

Description

Research & Mechanisms

1. Synergistic Tissue Repair The primary research interest in this blend is the complementary action of its components. While BPC-157 is often studied for its localized effects on angiogenesis (new blood vessel formation) and fibroblast activity, TB-500 is investigated for its systemic potential to promote cell migration to sites of injury. Hypotheses suggest that their combined administration may accelerate recovery parameters more effectively than either peptide alone.

2. Inflammation and Fibrosis Modulation Both peptides have demonstrated properties related to the modulation of inflammatory cytokines in animal models. Research suggests that this combination may offer a dual-pathway approach to reducing oxidative stress and preventing excessive fibrosis (scar tissue formation) during the healing process of soft tissues.

3. Angiogenesis and Blood Flow Experimental data indicates that both BPC-157 and TB-500 play roles in vascular development. BPC-157 is linked to the upregulation of VEGFR2, while TB-500 promotes endothelial cell migration. This blend is frequently used in studies focusing on ischemic recovery and the revascularization of damaged tissues.